Conditions: Actinic Keratoses
Allocation: RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 26
Healthy volunteers: no

Brief summary:
The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)

Detailed description:

Arms:
arm 1: Metvix® (160mg/g) and Photodynamic Therapy Daylight One session at baseline arm 2: Metvix® (160mg/g) and Photodynamic Therapy Blue light One session at baseline

Interventions: intervention 1: Metvix® intervention 2: Photodynamic Therapy Blue light intervention 3: Photodynamic Therapy Daylight
Intervention descriptions: intervention 1: None intervention 2: Photodynamic therapy (PDT) is a medical treatment that utilizes a photosensitizing molecule (Metvix) and a blue light source to activate the applied drug intervention 3: Photodynamic therapy (PDT) is a medical treatment that utilizes a photosensitizing molecule (Metvix) and a the day light to activate the applied drug

Protocol document: